Search results
Results From The WOW.Com Content Network
Difficulty in processing information and planning. Loss of memory. Having trouble understanding visual information. Changes in attention or alertness. Movement problems that include stiffness ...
Symptoms. Effects of long-term benzodiazepine use may include disinhibition, impaired concentration and memory, depression, [19][20] as well as sexual dysfunction. [6][21] The long-term effects of benzodiazepines may differ from the adverse effects seen after acute administration of benzodiazepines. [22] An analysis of cancer patients found ...
Nearly 1 in 5 dementia cases could be associated with vision impairment, according to a study published Thursday, suggesting better eye health could help to lower the diagnosis rate. Dementia does ...
Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens, [ 2 ] and is the cause of 60–70% of cases of dementia. [ 2 ][ 15 ] The most common early symptom is difficulty in remembering recent events. [ 1 ] As the disease advances, symptoms can include problems with language, disorientation ...
Signs and symptoms. Frontotemporal dementia is an early onset disorder that mostly occurs between the ages of 45 and 65, [13] but can begin earlier, and in 20–25% of cases onset is later. [11][14] Men and women appear to be equally affected. [15] It is the most common early presenting dementia. [16]
That’s because you can get a corneal ulcer, which is an infection on part of the eye that a contact covers. “It’s not going to happen every time, but when it happens, it’s terrible ...
Sundowning. Sundowning, or sundown syndrome, [1] is a neurological phenomenon associated with increased confusion and restlessness in people with delirium or some form of dementia. It is most commonly associated with Alzheimer's disease but is also found in those with other forms of dementia.
After 670 days, there were 1,172 new diagnoses of dementia among the study participants. When compared with people who took DPP-4 inhibitors, those who took SGLT-2 inhibitors had a 35 percent ...